Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for rare liver diseases. Based in Foster City, California, the company has built a portfolio of treatments addressing cholestatic conditions and other hepatobiliary disorders, and it operates with a global reach through affiliates and commercial partners. Mirum’s lead products are indicated for rare pediatric and adult liver diseases, and the company invests heavily in research to expand its pipeline beyond its initial approvals.
In Spain, Mirum is expanding its commercial footprint to support the uptake of its hepatology treatments, opening two field-based roles (Regional Account Manager, South Spain and North Spain) to manage healthcare professional relationships in the hepatology space. The company is an attractive option for international professionals with experience in rare disease therapeutics, as it offers a mission-driven environment and a growing territory. Mirum’s approach emphasizes close engagement with medical specialists and patient communities, making it a fit for candidates who value meaningful impact and cross-border collaboration.
Company History
Founded in 2015, Mirum Pharmaceuticals quickly advanced its lead compound maralixibat for rare cholestatic diseases, gaining FDA approval for LUMRYZ for ALGS in 2021 and later expanding to other indications. The company has grown through acquisitions and global partnerships, establishing its presence in the US, Europe, and beyond.
For International Professionals
- Mirum is a rare-disease focused biopharma, which may be attractive to professionals seeking meaningful patient impact
- The company has a global clinical trial network, offering potential for international collaboration
- Field roles in Spain cover whole regions (North/South), likely requiring frequent travel but offering flexibility
- Mirum and its staff have won recognition as a top employer in prior years, indicating a positive work culture.
- As a small to mid-sized firm (~300), hires may enjoy more autonomy and visibility than at large pharma firms.
Open Positions (0)
No open positions right now. Check back soon!
Browse all jobs